SCHEMBL30363501

SCHEMBL30363501

CCSC1=N/C(=C\c2ccc3ncccc3c2)C(=O)N1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.62
▸ DYRK3 O43781 7/20 0.57
▸ PIM1 P11309 4/20 0.57
▸ CSNK2A2 P19784 4/20 0.57
▸ CSNK2B P67870 4/20 0.57
▸ CSNK2A1 P68400 4/20 0.57
▸ DYRK1A Q13627 4/20 0.57
▸ DYRK2 Q92630 4/20 0.57
▸ DYRK1B Q9Y463 4/20 0.57
▸ CSNK2A3 Q8NEV1 3/20 0.57
▸ HPGD P15428 2/20 0.57
▸ ALDH1A1 P00352 1/20 0.57
▸ PIK3CD O00329 1/20 0.49
▸ PIK3CA P42336 1/20 0.49
▸ PIK3CG P48736 1/20 0.49
▸ CLK1 P49759 1/20 0.49
▸ CLK3 P49761 1/20 0.49
▸ HASPIN Q8TF76 1/20 0.49
▸ MYLK2 Q9H1R3 1/20 0.49
▸ CLK4 Q9HAZ1 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24904313 1.00 KDM4E (0.62) KDM4EDYRK3PIM1CSNK2A2CSNK2B
SCHEMBL30363342 0.87 MAPT (0.57) KDM4EDYRK3PIM1CSNK2A2CSNK2B
SCHEMBL26095459 0.87 MAPT (0.57) KDM4EDYRK3PIM1CSNK2A2CSNK2B
SCHEMBL30363461 0.86 KDM4E (0.64) KDM4EDYRK3PIM1CSNK2A2CSNK2B
SCHEMBL24904263 0.86 KDM4E (0.64) KDM4EDYRK3PIM1CSNK2A2CSNK2B
SCHEMBL30363474 0.83 KDM4E (0.58) KDM4EDYRK3PIM1CSNK2A2CSNK2B
SCHEMBL26093545 0.83 KDM4E (0.58) KDM4EDYRK3PIM1CSNK2A2CSNK2B
SCHEMBL26095105 0.79 KDM4E (0.58) KDM4EDYRK3PIM1CSNK2A2CSNK2B
SCHEMBL24904266 0.79 KDM4E (0.60) KDM4EDYRK3PIM1CSNK2A2CSNK2B
SCHEMBL23510493 0.78 CLK1 (0.60) KDM4EDYRK3PIM1CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4422747-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2024-09-04 — — EP disclosed
WO-2023072969-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 PERHA PHARMACEUTICALS (FR) 2023-05-04 — — WO disclosed
Send feedback